< Back to previous page
Researcher
Lorenz Van der Linden
- Disciplines:Biomarker discovery and evaluation, Drug discovery and development, Medicinal products, Pharmaceutics, Pharmacognosy and phytochemistry, Pharmacology, Pharmacotherapy, Toxicology and toxinology, Other pharmaceutical sciences
Affiliations
- Clinical Pharmacology and Pharmacotherapy (Division)
Member
From1 Oct 2014 → Today
Projects
1 - 4 of 4
- Gastrointestinal physiology and drug disposition in geriatric patientsFrom5 Aug 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Optimizing medical-pharmaceutical care to reduce hospital readmissions in older adultsFrom1 Oct 2020 → TodayFunding: FWO fellowships
- Optimizing drug therapy in high risk older patientsFrom23 Sep 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Improving drug use in older adults during hospital stayFrom1 Oct 2013 → 27 Sep 2018Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
1 - 10 of 81
- Therapy and guideline adherence at a multidisciplinary hypertension clinic: A prospective, observational study(2024)
Authors: Peter Verhamme, Lorenz Van der Linden
- Comment on: Anti-Coagulant Treatment of Cancer-Associated Thrombosis in Frail Patients: Impact of Frailties on the Management of Drug-Drug Interactions.(2024)
Authors: Lorenz Van der Linden, Lucas Van Aelst
Pages: 395 - 396 - Agreement Between a Colorimetric Assay and Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry for Quantifying Paracetamol Plasma Concentrations(2024)
Authors: Erwin Dreesen, Karel Allegaert, Lorenz Van der Linden, Jos Tournoy
- Predictors for unplanned hospital admissions in community dwelling adults: A dynamic cohort study(2023)
Authors: Laura Hellemans, Bert Vaes, Jos Tournoy, Lorenz Van der Linden
Pages: 1432 - 1439 - Should vericiguat be initiated in geriatric inpatients with heart failure with reduced ejection fraction and a worsening heart failure event prior to discharge?(2023)
Authors: Laura Hellemans, Jos Tournoy, Christophe Vandenbriele, Lucas Van Aelst, Lorenz Van der Linden
Pages: 367 - 369 - Pharmacokinetic drug-drug interactions with direct anticoagulants in the management of cancer-associated thrombosis(2023)
Authors: Lorenz Van der Linden, Thomas Vanassche, Lucas Van Aelst, Peter Verhamme
Pages: 2369 - 2376 - Guideline-Directed Medical Therapies for Heart Failure with a Reduced Ejection Fraction in Older Adults: A Narrative Review on Efficacy, Safety and Timeliness(2023)
Authors: Lorenz Van der Linden, Jos Tournoy, Christophe Vandenbriele, Lucas Van Aelst
Pages: 691 - 702 - The impact of a pharmacist intervention on post-discharge hypnotic drug discontinuation in geriatric inpatients: a before-after study(2023)
Authors: Lorenz Van der Linden, Laura Hellemans, Koen Milisen, Jos Tournoy
- Community pharmacists' perceptions on multidisciplinary heart failure care: an exploratory qualitative study(2023)
Authors: Willem Raat, Lorenz Van der Linden, Bert Vaes, Miek Smeets
- The PREPARE study benefits of pharmacogenetic testing are unclear(2023)
Authors: Lorenz Van der Linden
Pages: 1851 - 1851